Product Images Fludeoxyglucose F 18
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 2 images provide visual information about the product associated with Fludeoxyglucose F 18 NDC 76376-618 by Hamamatsu/queen�s Pet Imaging Center, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Chemical structure of Fludeoxyglucose F 18 - fludeoxyglucose f 18 injection usp 01
PRINCIPAL DISPLAY PANELNDC# 76376-618-3030 mL Multiple-Dose VialFludeoxyglucose F 18 Injection, USP - fludeoxyglucose f 18 injection usp 02
Fludeoxyglucose F 18 Injection, USP is a diagnostic solution that is used for intravenous injection only. It comes in a 30mL multiple-use vial with a concentration range of 10-100 mCi/mL at the end of synthesis, and it has a shelf life of 12 hours after the end of synthesis. The solution is sterile, non-pyrogenic, and contains deoxy-2 [18F] fluoro-D-glucose 0.37–37.0 GBq (10-100 mCi) of no barrier added 2-deoxy-2-[18F]fluoro-D-glucose at EOS, [72 meq of citrate ions. It should be stored at 25°C (77°F) with excursions allowed to 15-30°C (56-86°F) according to USP controlled room temperature. It must be stored upright in a shielded container, and doses should be handled and withdrawn aseptically. The solution has a half-life of 109.7 minutes, and the manufacturer is Hamamatsu/Queen's Pet Imaging Center located in Honolulu, HI. Patients should not be given the solution if it contains particulate matter, and correct dosage calculations should be made from the calibration date and time.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.